General Information of This Metabolic Reaction (MR) (ID:
MR009849) |
Formula |
|
Reactant |
Ambrisentan |
Product |
4-hydroxymethyl?ambrisentan |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Cytochrome P450 3A5 (CYP3A5)
|
DME Info
|
Mephenytoin 4-hydroxylase (CYP2C19)
|
DME Info
|
Metabolic Type
|
Oxidation
-
Oxidation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
Effect of ketoconazole on the pharmacokinetic profile of ambrisentan. J Clin Pharmacol. 2009 Jun;49(6):719-24.
|
2 |
Clinical pharmacokinetics and drug-drug interactions of endothelin receptor antagonists in pulmonary arterial hypertension. J Clin Pharmacol. 2012 Dec;52(12):1784-805.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.